FdaApplication
ANDA 206199
Identifiers
- fda_app_no: ANDA206199
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2020-07-27 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OXACILLIN SODIUM | OXACILLIN SODIUM | EQ 10GM BASE/VIAL | INJECTABLE;INJECTION |
1 product